Type A Botulinum Toxin Market Size, Share and Trends Analysis Report, By Type (onabotulinumtoxinA, abobotulinumtoxinA, incobotulinumtoxinA, and prabotulinumtoxinA), By Application (Cervical Dystonia, Muscle Spasm, Overactive Bladder, Hyperhidrosis, and Migraine), By End-user (Hos[pitals, Speciality Clinics, and Others), Forecast (2022-2028)

The global type A botulinum toxin market is anticipated to grow at a considerable CAGR of 7.4% during the forecast period (2022-2028). Type A botulinum toxic is a type of botulinum toxic that is used for the treatment of several conditions including cervical dystonia, muscle spasm, hyperhidrosis, and others by blocking acetylcholine release. Type A botulinum toxin also has its application in cosmetic products. The major factor attributing to the growth of the global type A botulinum toxin market includes the rising prevalence of cervical dystonia. According to the National Organization for Rare Disease (NORD), the exact number of cervical dystonia across the globe is unknown, however, around 60,000 people are estimated to live with cervical dystonia in the US alone in 2021. Furthermore, the rising prevalence of hyperhidrosis is also increasing the demand for type A botulinum toxin, contributing to the growth of the market. According to the American Journal of managed care (AJMC), around 15.3 million people are impacted by hyperhidrosis in the US in 2016. Hyperhidrosis is the condition of excessive sweating beyond physiological necessity.

In addition, another factor driving the growth of the market is the application of type A botulinum toxin in the overactive bladder. According to the National Library of Medicine (NIH), around 33 million adults are suffering from overactive bladder in the US alone in 2021. Furthermore, increasing cases of migraine or headaches across the globe is also driving the demand for type A botulinum toxin. According to the World Health Organization (WHO), migraine is the primary headache disorder mostly affecting people between the ages of 35 years to 45 years. Half or three-quarters of the total population aged 18 years to 65 years had headache disorder in 2016. Among these, 30% of cases of headache disorder are migraine.

The market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new product launches, to stay competitive in the market. For instance, in March 2022, AbbVie Inc. published the data of its neuroscience portfolio showing the new data of onabotulinumtoxinA in the treatment of spasticity and cervical dystonia.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
  • By End-user
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- Pfizer Inc., AbbVie Inc., Galderma Holdings SA, Ipsen, and Merz GmbH & Co. KGaA, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Type A Botulinum Toxin  Market Report by Segment

By Type

• onabotulinumtoxinA
• abobotulinumtoxinA
• incobotulinumtoxinA
• prabotulinumtoxinA

By Application

• Cervical Dystonia
• Muscle Spasm
• Migraine
• Hyperhidrosis
• Overactive Bladder

By End-user

• Hospitals
• Speciality Clinics
• Others

Global Type A Botulinum Toxin  Market Report by Region

North America

• The United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa